hero image
Patricia Gauthier - Consulate General of Canada (CTA Boston). Boston, MA, US

Patricia Gauthier

Global Commercialization Lead, Rare Diseases and Latent Virus | Moderna


Patricia Gauthier is actively involved in organizations that are committed to rethinking innovation and inspiring leadership.



Patricia Gauthier joined Moderna at the end of 2020 as General Manager to set up and lead Moderna's Canadian organization. She played a key role in Moderna's response to the COVID-19 pandemic in Canada, and quickly established collaborative relationships with government and other life sciences stakeholders.

Before joining Moderna, Patricia spent 12 years at pharmaceutical giant GSK, holding key senior roles including Head of the Vaccines Business Unit and Head of Government Affairs and Market Access.

Patricia Gauthier's professional path has taken her to all corners of the world, living in the United States, Singapore and France, as well as London while working as a lawyer at McCarthy Tétrault. In addition to her legal studies, Patricia holds an MBA from HEC Montréal and certifications in strategic negotiation from Harvard Business School and in leadership from IMD.

Originally from Trois-Rivières, Patricia Gauthier has been based in Toronto for over a decade with her family. She is actively involved in organizations that are committed to rethinking innovation and inspiring leadership, like the Creative Destruction Lab, and from 2015-2019 she served as a board member of NEOMED, which fosters commercial opportunities for biotechnology innovations.

Industry Expertise (4)


Health Care - Providers

Health Care - Facilities

Health Care - Services

Areas of Expertise (5)

Pharmaceutical Sales

Government Affairs

Strategic Negotiations

COVID-19 Response Strategies

Vaccine Manufacturing

Education (2)

HEC Montréal: MBA 2008

Université de Sherbrooke: LLB, Law 2001





2022 CGCA - Business Achievement Award Recipient: Patricia Gauthier


Accomplishments (1)

CGCA - Business Achievement Award (professional)


Selected Media Appearances (8)

We are updating the vaccine to target Omicron: President of Moderna Canada

Bloomberg  tv


Patricia Gauthier, president and general manager at Moderna Canada, joins BNN Bloomberg to discuss how the company's updated vaccine will offer broader protection and last longer.

view more


Yahoo! Finance  online


"As the COVID-19 virus evolves, so must the vaccines. An updated vaccine will ensure Canadians have the most current and effective option to keep them protected. We have initiated our submission with Health Canada and, pending approval, will be ready to supply an XBB monovalent vaccine in time for the fall," said Patricia Gauthier, President and General Manager, Moderna Canada.

view more

Province announces $4M investment to bring mRNA vaccine production to Cambridge

CBC News  online


"Today is a very important milestone in that commitment," said president of Moderna Canada, Patricia Gauthier. "Moderna will now be able to deliver domestic ... mRNA vaccine production, ensuring Canadians have secure, on shore, direct access to our mRNA vaccines for future pandemic and health emergencies."

view more

Talk by Patricia Gauthier, President and General Manager of Moderna Canada

The Chamber of Commerce of Metropolitan Montreal  online


Patricia Gauthier looked back at what she accomplished up to this point as the person responsible for bringing Moderna to Canada. In a short amount of time, the company went from being relatively unknown to Canadians to one that has big plans for Canada.

view more

Moderna’s Patricia Gauthier is preparing Canada for the next pandemic

Maclean's  online


The company’s first Canadian general manager is laying the groundwork for the country to become a leader in vaccine production

view more

Moderna is setting up a new office in Canada. The Star talked to its new Canadian head about plans for a new vaccine production facility, conspiracy theories and why mRNA vaccines work

Toronto Star  online


To call Patricia Gauthier’s introduction to Moderna Canada “intense” would be an understatement. After years at GSK Canada in government affairs and market access, pharma trade strategy and product management, she was tapped to be Moderna’s first hire in Canada.

view more

Meet 50 emerging leaders reinventing how Canada does business

The Globe and Mail  online


On Nov. 30, 2020, U.S.-based pharmaceutical and biotech company Moderna completed Phase 3 clinical trials of its mRNA-1273 vaccine, announcing it was 94.1% effective against COVID-19. That same day, Patricia Gauthier became Moderna’s first—and, for two months, sole—Canadian hire.

view more

Head of Moderna operations in Canada discusses COVID variants

CityNews  tv


Mel speaks with the general manager of Moderna operations in Canada, Patricia Gauthier, about how current vaccines will hold up against dangerous variants.

view more